<DOC>
	<DOCNO>NCT00751751</DOCNO>
	<brief_summary>To assess efficacy individually optimized dos olmesartan medoxomil compare losartan elderly elderly patient essential hypertension . The study hypothesis non-inferiority olmesartan medoxomil compare losartan lower mean sit diastolic blood pressure 12 week treatment compare baseline . The study duration 60 week , include 52-week treatment period . After 12 week treatment hydrochlorothiazide may add control blood pressure . Efficacy safety measurement carry 18 visit trial .</brief_summary>
	<brief_title>Olmesartan Medoxomil Versus Losartan Elderly Very Elderly</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age 65 year old Mean sit diastolic BP = 100114 mmHg mean sit systolic BP &gt; =150 mm HG Secondary hypertension Malignant hypertension Severe heart failure ( NYHA IIIIV ) History evidence renal disease Recent history myocardial infarction Hypersensitivity study drug History drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>